Rosenblatt cuts Cerebras stock price target to $170 on valuation
Rosenblatt Securities cut its price target for Cerebras Systems (CBRS) to $170 from a prior target, maintaining a Buy rating. The firm reduced its valuation multiple due to broader AI sector pressure and competitive dynamics. Cerebras shares have fallen 65% since Q2 2026 earnings, trading at $89.68. Rosenblatt noted Cerebras' multiyear OpenAI contract and strong inference technology but cited peer valuation compression. Other analysts have mixed price targets, ranging from $175 to $300.
How this was made
The 30-second read
Why it matters
Analyst target cuts often precede short‑term price adjustments, especially ahead of earnings.
Market read
The price target reduction may trigger further downside as investors reassess valuation multiples.
What to watch
Potential upside from the multiyear OpenAI contract and upcoming CS‑4 system launch.
Background
Cerebras has faced a steep share decline since Q2 2026 earnings and is navigating AI market dynamics.
Ticker impact
Rosenblatt Securities lowered its price target on Cerebras Systems to $170, citing valuation concerns and AI market pressure.
likely pressure as the market prices in the lower valuation multiple
The target reduction from prior levels and the mention of a 65% share decline indicate a bearish outlook.
Market effects
The downgrade reflects broader pressure on AI‑related semiconductor stocks.
US semiconductor sector may see modest pullback.
Limited to AI hardware niche; no immediate global macro effect.
Counterpoint
Some investors may view the lower target as a buying opportunity given the oversold RSI.
Key entities
- analystRosenblatt Securities
Equity research firm that lowered CBRS price target.
- companyCerebras Systems
AI hardware company whose stock is being analyzed.
